MENU
SPRO
AS OF
Nov 21 closing price
Price
$2.31
Change
+$0.05 (+2.21%)
Capitalization
130.14M
123 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Spero Therapeutics (SPRO) Ownership - Who owns Spero Therapeutics?

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
130.14M
P/E Ratio
10.75
Total Cash
31.19M
Projected Growth
N/A
Total Debt
3.62M
Revenue
34.09M
Risk (Beta)
4.10
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price

Fundamentals

SPRO
Capitalization
130M
P/E Ratio
10.75
Risk (Beta)
4.10
Dividend Yield
N/A
Total Cash
31.2M
Total Cash/Share
0.55
Total Debt
3.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.53%
Revenue
34.1M
ROE
N/A
Book Value
32.8M
P/B Ratio
4.91
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
56K
Current Ratio
3.97
Current Revenue Per Employee
368812.50
Dividends Per Share - Security
N/A
EBITDA
-56.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.57
Shares Held By Institutions
37M
Shares Outstanding - Current
56.3M
Total Liabilities
29.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
124.272
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SPRO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRO showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for SPRO
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com